ArticleMedicine2026
The role of circulating cytokines in eosinophilic esophagitis: A Mendelian randomization and gene expression analysis study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore potential causal relationships between 91 circulating inflammatory cytokines and eosinophilic esophagitis (EoE) using a two-sample Mendelian randomization (MR) framework, with findings further examined at the transcriptomic level. We conducted a two-sample MR analysis utilizing summary-level genome-wide association studies data. The inverse-variance weighted method was used for the primary analysis, supplemented by sensitivity analyses (MR-Egger, weighted median) to assess pleiotropy. A false discovery rate (FDR) was applied to correct for multiple comparisons. Subsequently, we performed a differential expression analysis of the GSE197702 dataset, containing esophageal biopsies from a pediatric cohort with a significance threshold of adjusted P-value < .05. Our MR analysis identified nominally significant associations where genetically predicted higher levels of interleukin-8 (IL-8) and C-C motif chemokine ligand 19 (CCL19) were associated with an increased risk of EoE, whereas higher levels of hepatocyte growth factor were associated with a decreased risk (P < .05; P_fdr < .2). Sensitivity analyses showed no evidence of significant horizontal pleiotropy. Complementing the genetic finding for IL-8, our transcriptomic analysis observed that the gene encoding IL-8, chemokine ligand 8 (CXCL8), was upregulated in esophageal tissues from EoE patients compared to healthy controls. Integrating genetic and transcriptomic insights, this study suggests a potential link between the IL-8 pathway and EoE pathogenesis. Given that the MR associations were suggestive after FDR correction, these findings should be considered exploratory. Nevertheless, they highlight the IL-8 pathway as a candidate target warranting further mechanistic and clinical validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.